Which hedge funds own CADL? CANDEL THERAPEUTICS INC, Q2 2026 13F holders
22 tracked hedge funds disclosed a position in CADL (CANDEL THERAPEUTICS INC) in their Q2 2026 13F filings, worth $126.8m in total. The largest holder by portfolio weight is Saturn V Capital Management LP at 4.9% of its book. 9 opened a new position this quarter: Militia Capital Management LLC, Y-Intercept (Hong Kong) Ltd, Trexquant Investment LP, Jain Global LLC. 6 exited: Stonepine Capital Management, LLC, Vestal Point Capital, LP, ExodusPoint Capital Management, LP.
- 22
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 9
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 6
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $8.2m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $8.0m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $127m
- Combined value Sum of the holders' reported positions in the security.
- 1.8%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Stonepine Capital Management, LLC | 0.4% | $502k |
| Vestal Point Capital, LP | 0.2% | $5.5m |
| ExodusPoint Capital Management, LP | 0.01% | $1.1m |
| Mirabella Financial Services LLP | 0.01% | $61.2k |
| Woodline Partners LP | 0.0% | $768k |
| Renaissance Technologies LLC | 0.0% | $62.6k |
Ownership over time
Who discovered CADL first? Beta
The run: Q3 2023 → Q4 2024, +843%
| Saturn V Capital Management LP | Q1 2026 | – | +2.8 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.